Evidence map›Paper›PMID 29081413›Full record

ArticleCancer biomarkers : section A of Disease markers2017

Targeting of miR-150 on Gli1 gene to inhibit proliferation and cell cycle of esophageal carcinoma EC9706.

Jiachun Sun, Dengkui Wang, Xiangming Li, Junqiang Yan, Xiaozhi Yuan, Wei Wang

Abstract read
In one paragraph

Article in Cancer biomarkers : section A of Disease markers, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Gli1, a potential cancer stem cell marker, is strongly associated with prognosis in prostate cancer.International journal of clinical and experimental pathology · 2018
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jiachun SunHenan Key Laboratory of Cancer Epigenetics, Cancer Institute, Henan, China.
Dengkui WangClinical Laboratory, Henan University of Science and Technology First Affiliated Hospital and Clinical Medical College, Luoyang 471003, Henan, China.
Xiangming LiDepartments of Orthopedics, Henan University of Science and Technology First Affiliated Hospital and Clinical Medical College, Luoyang 471003, Henan, China.
Junqiang YanNeurological Diseases Institute, Henan University of Science and Technology First Affiliated Hospital and Clinical Medical College, Luoyang 471003, Henan, China.
Xiaozhi YuanHenan Key Laboratory of Cancer Epigenetics, Cancer Institute, Henan, China.
Wei WangHenan Key Laboratory of Cancer Epigenetics, Cancer Institute, Henan, China.
First Affiliated Hospital of Henan University of Science and Technology · CNHenan Cancer Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveGlioma-associated oncogene homolog 1 (Gli1) in Hedgehog signal pathway regulates Cyclin D1 expression, cell cycle or proliferation modulation. Esophageal cancer patients had significantly elevated Gli1 expression, which is related with survival and prognosis. It has been demonstrated that the level of miR-150 was decreased in esophageal cancer patients compared to normal control. As a complementary relationship exists between miR-150 and 3'-UTR of Gli1, this study investigated if miR-150 played a role in regulating Gli1 expression, and proliferation or cell cycle of esophageal cancer cells. PATIENTS AND

methodsEsophageal squamous cell carcinoma (ESCC) patients from our hospital were recruited to collect tumor and adjacent tissues for miR-150 and Gli1 expression. Esophageal carcinoma cell line EC9706 and normal esophageal epithelial cell line HEEC were compared for expression of miR-150, Gli1 and Cyclin D1. Dual luciferase reporter gene assay examined the targeted relationship between miR-150 and 3'-UTR of Gli1. In vitro cultured EC9706 cells were treated with miR-150 mimic, si-Gli1 or the combination of miR-150 mimic and si-Gli1, respectively, to check their gene expression, cell cycle and proliferation.

resultsESCC tissues had significantly higher Gli1 expression and lower miR-150 expression. EC9706 cell also had higher Gli1 expression than that in HEEC, whilst miR-150 was down-regulated. Via targeting 3'-UTR of Gli1 gene, miR-150 inhibited its expression. Transfection of miR-150 mimic, si-Gli1 or the combination of miR-150 mimic and si-Gli1, respectively, remarkably decreased expression of Gli1 and Cyclin D1 expression in EC9706 cells, whose cell cycle arresting at G0/G1 phase was enhanced with weakened proliferation.

conclusionsMiR-150 can induce G0/G1 cell cycle arresting and weaken proliferation of esophageal carcinoma cells via targeted inhibition on Gli1 and downstream expression of Cyclin D1.

Indexed as

3' Untranslated RegionsAdultAgedBase SequenceCarcinoma, Squamous CellCell Cycle CheckpointsCell LineCell Line, TumorCell ProliferationEsophageal NeoplasmsFemaleGene Expression Regulation, NeoplasticHEK293 CellsHumansMaleMicroRNAs3' Untranslated RegionsGLI1 protein, humanMicroRNAsMIR150, humanZinc Finger Protein GLI1cell cyclecell proliferationCyclin D1esophageal carcinomaGli1MicroRNA-150

Identifiers

PMID29081413
PMCPMC13075756
OpenAlexW2766529247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.